首页|硝苯地平结合硫酸镁注射液对妊娠期高血压症产妇血压水平、脐动脉阻力指数及症状改善时间的影响

硝苯地平结合硫酸镁注射液对妊娠期高血压症产妇血压水平、脐动脉阻力指数及症状改善时间的影响

扫码查看
目的 探究硝苯地平结合硫酸镁注射液对妊娠期高血压(妊高症)产妇血压水平、脐动脉阻力指数及症状改善时间的影响.方法 选择 2020 年6 月—2023年 6 月金乡县人民医院收治的 80 例妊高症产妇为研究对象,按随机数字表法将其分为对照组及观察组,每组 40 例.对照组采用硫酸镁注射液治疗,观察组在此基础上采用硝苯地平治疗.比较两组患者的血压水平、脐动脉阻力指数、症状改善时间及不良反应发生情况.结果 治疗后,观察组的收缩压、舒张压分别为(124.49±9.27)mmHg(1 mmHg=0.133 kPa)、(78.50±3.86)mmHg,均低于对照组的(141.37±10.58)mmHg、(90.34±5.18)mmHg,组间差异有统计学意义(P<0.05);观察组的脐动脉阻力指数、血黏度分别为(2.41±0.28)、(2.58±0.26)mPa·s,均低于对照组的(3.28±0.35)、(3.65±0.34)mPa·s,组间差异有统计学意义(P<0.05).观察组的水肿、晕眩、蛋白尿改善时间分别为(6.20±1.14)d、(9.86±2.53)d、(12.48±2.09)d,均短于对照组的(8.73±1.55)d、(13.05±3.38)d、(16.11±2.13)d,组间差异有统计学意义(P<0.05).两组的不良反应发生率比较,差异无统计学意义(P<0.05).结论 硝苯地平结合硫酸镁注射液可降低妊高症产妇的血压水平及脐动脉阻力指数,加速临床症状改善,且药物安全性较佳.
Effects of Nifedipine Combined with Magnesium Sulfate Injection on Blood Pressure Level,Umbilical Artery Resistance Index and Symptom Improvement Time in Pregnant Women with Pregnancy Induced Hypertension
Objective To explore the effects of nifedipine combined with magnesium sulfate injection on the blood pressure level,umbilical artery resistance index and symptom improvement time of pregnant women with pregnancy induced hypertension(PIH).Methods 80 pregnant women with PIH admitted to Jinxiang County People's Hospital from June 2020 to June 2023 were selected as the study subjects and were divided into a control group and an observation group according to random number table method,with 40 cases in each group.The control group was treated with magnesium sulfate injection,and the observation group was treated with nifedipine on this basis.The blood pressure,umbilical artery resistance index,symptom improvement time and adverse reactions were compared between the two groups.Results After treatment,the systolic blood pressure and diastolic blood pressure of the observation group were(124.49±9.27)mmHg(1 mmHg=0.133 kPa)and(78.50±3.86)mmHg,respectively,which were lower than(141.37±10.58)mmHg and(90.34±5.18)mmHg of the control group,the differences between the groups were statistically significant(P<0.05);the umbilical artery resistance index and blood viscosity in the observation group were(2.41±0.28)and(2.58±0.26)mPa·s,respectively,which were lower than(3.28±0.35)and(3.65±0.34)mPa·s in the control group,and the differences between the groups were statistically significant(P<0.05).The improvement time of edema,dizziness and proteinuria in the observation group was(6.20±1.14)d,(9.86±2.53)d and(12.48±2.09)d,respectively,which was shorter than(8.73±1.55)d,(13.05±3.38)d and(16.11±2.13)d of the control group,the differences between the groups were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P<0.05).Conclusion Nifedipine combined with magnesium sulfate injection can reduce the level of blood pressure and umbilical artery resistance index of pregnant women with PIH,accelerate the improvement of clinical symptoms,and the drug safety is better.

Pregnancy induced hypertensionNifedipineMagnesium sulfateBlood pressure levelUmbilical artery resistance index

赵丽云

展开 >

金乡县人民医院产科,山东济宁 272200

妊娠期高血压 硝苯地平 硫酸镁 血压水平 脐动脉阻力指数

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(2)
  • 10